Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Bristol Myers Squibb (BMY) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 46 quarters since 2010. Compare with BMY stock chart to see long term trends.

BMY stock compared to

BMY Income Statement

Revenue, Net:11703000000
Revenue Per Share:5.26
Cost of Goods & Services Sold:2452000000
Selling, General & Admin Expense:1882000000
Research & Development Expense:3271000000
Total Operating Expenses:10150000000
Operating Income:1553000000
Income Taxes:492000000
Net Income:1061000000
Earnings Per Share, Basic:0.47
Shares Outstanding, Basic Avg:2227000000

BMY Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:2712000000
Net Cash from Operations:3060000000
Repurchases/Buybacks Common Stock:1236000000
Cash Dividends Paid:1099000000
Net Cash from Financing Activities:-3182000000
Property, Plant & Equipment Purchases:210000000
Purchases of Businesses, Net of Cash:366000000
Net Cash from Investing Activities:180000000
Net Change in Cash & Equivalents:76000000

BMY Balance Sheet

Cash and Cash Equivalents:11397000000
Short-Term Investments:1946000000
Accounts Receivable, Net:7713000000
Inventories:2137000000
Total Current Assets:29161000000
Property, Plant & Equipment, Net:5795000000
Total Assets:110797000000
Accounts Payable:3609000000
Current Portion of Long-Term Debt:2497000000
Total Short-Term Liabilities:18991000000
Long Term Debt, Non-Current Portion:42503000000
Total Liabilities:73923000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
200,065,592 sh
-3,822,794 sh
-2%
$12,061,953
$73,315
Blackrock Inc.
162,409,990 sh
-1,232,428 sh
-1%
$9,791,698
$169,524
FMR LLC
62,626,025 sh
-2,957,096 sh
-5%
$3,775,723
-$80,565
Wellington Management Group Llp
53,988,407 sh
-9,663,365 sh
-15%
$3,254,959
-$487,765
Bank Of America Corp /De/
32,888,864 sh
32,573,264 sh
10321%
$1,982,870
$1,964,313
Renaissance Technologies LLC
30,576,427 sh
-12,920,704 sh
-30%
$1,843,453
-$714,178
Berkshire Hathaway Inc
29,971,194 sh
29,971,194 sh
NEW
$1,806,963
$1,806,963
Ameriprise Financial Inc
29,395,030 sh
-2,128,869 sh
-7%
$1,771,901
-$82,486
Northern Trust Corp
29,053,371 sh
-948,647 sh
-3%
$1,751,629
-$12,489
Dodge & Cox
27,199,986 sh
-1,355,403 sh
-5%
$1,639,887
-$39,170
Invesco Ltd.
21,207,922 sh
-1,736,908 sh
-8%
$1,278,628
-$70,528
Morgan Stanley
21,162,568 sh
1,729,408 sh
9%
$1,275,891
$133,222
Primecap Management Co/Ca/
19,963,725 sh
-660,070 sh
-3%
$1,203,613
-$9,066
Legal & General Group Plc
14,312,282 sh
-447,296 sh
-3%
$862,824
-$4,943
Charles Schwab Investment Management Inc
10,500,911 sh
-661,878 sh
-6%
$633,101
-$23,272
UBS Asset Management Americas Inc
8,627,918 sh
267,440 sh
3%
$520,177,177
$28,581,070
Goldman Sachs Group Inc
8,592,415 sh
8,464,215 sh
6602%
$518,037
$510,499
Price T Rowe Associates Inc /Md/
6,877,241 sh
-1,766,224 sh
-20%
$414,629
-$93,607
Royal Bank Of Canada
6,576,161 sh
6,201,161 sh
1654%
$396,476
$374,426
Prudential Financial Inc
5,356,054 sh
-72,692 sh
-1%
$322,917
$3,707

Data imported from Bristol Myers Squibb SEC filings. Check original filings before making any investment decision.